<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJGas</journal-id><journal-title-group><journal-title>Open Journal of Gastroenterology</journal-title></journal-title-group><issn pub-type="epub">2163-9450</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojgas.2021.115008</article-id><article-id pub-id-type="publisher-id">OJGas-109483</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Digestive Bleeding by Rupture of Esophageal Varicose Veins and Prognosis Value of Blood Transfusion in the Hepatogastroenterology Department of the Gabriel Toure Hospital
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>K.</surname><given-names>Doumbia</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>H.</surname><given-names>Sow</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>M.</surname><given-names>Y. Dicko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>S.</surname><given-names>D. Sanogo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>M.</surname><given-names>S. Tounkara</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>K.</surname><given-names>Péliaba</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>M.</surname><given-names>Koumaré</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>G.</surname><given-names>Soumaré</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>A.</surname><given-names>Konaté</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>M.</surname><given-names>T. Diarra</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>M.</surname><given-names>Y. Maiga</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Hepatogastroenterology, Teaching Hospital Gabriel Touré, Bamako, Mali</addr-line></aff><pub-date pub-type="epub"><day>27</day><month>05</month><year>2021</year></pub-date><volume>11</volume><issue>05</issue><fpage>75</fpage><lpage>80</lpage><history><date date-type="received"><day>1,</day>	<month>March</month>	<year>2021</year></date><date date-type="rev-recd"><day>25,</day>	<month>May</month>	<year>2021</year>	</date><date date-type="accepted"><day>28,</day>	<month>May</month>	<year>2021</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Digestive hemorrhage by rupture of esophageal Varices is common and has a pejorative prognosis in our context. 
  Purpose: The main purpose of this work was to study the digestive bleeding by esophageal varices and prognosis value of blood transfusion in the Hospital of Gabriel Tour&#233;. 
  Methodology: It was a prospective study that took place in the service of Hepato-gastroenterology of Gabriel Tour&#233; Hospital from June 2016 to May 2017 and from November 2017 to August 2018. 
  Results: At the end of the study, 77 patients met the inclusion criteria out of 1396 patients hospitalized during the same period. Varices bleeding represented a prevalence of 5.5% among hospitalized patients during the same period. The average age of our patients was 46.58 &#177; 15.09 years. The male sex was more reported in our study with a prevalence of 67.5%. At admission, 63.2% had clinical anemia, 58.4% low arterial pressure and 50.6% hemoglobin rate less than 7 g/dL. Blood transfusion was indicated in 47 patients (61%). The mortality rate was 23.4% and was comparable in both groups (p = 0.0990). Early rebleeding was significantly observed in the case of transfusion (p = 0.0452). Hepatic encephalopathy was the leading cause of death of our patients with 72.2%. 
  Conclusion: Digestive bleeding by esophageal varices is a worsen complication in cirrhosis in hospital setting. Transfusion has not significantly improved the prognosis of our patients.
 
</p></abstract><kwd-group><kwd>Esophageal Varices Bleeding</kwd><kwd> Blood Transfusion</kwd><kwd> Prognosis</kwd><kwd> Gabriel Tour&#233; Hospital</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Digestive bleeding by rupture of esophageal varicose veins is a common and severe complication of cirrhosis, occurring in 30% to 40% of patients with this condition. It is also the second leading cause of death in these patients [<xref ref-type="bibr" rid="scirp.109483-ref1">1</xref>]. Despite an improvement in management for more than 20 years, the six-week mortality of an episode of rupture of esophageal varicose veins remains high, between 15% and 35% on severe Child-Pugh C cirrhosis [<xref ref-type="bibr" rid="scirp.109483-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.109483-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.109483-ref4">4</xref>].</p><p>In France, its incidence is around 20% [<xref ref-type="bibr" rid="scirp.109483-ref5">5</xref>]. In Africa, the mortality rate was reported at 25% in Togo [<xref ref-type="bibr" rid="scirp.109483-ref6">6</xref>], 42.1% in Ouagadougou [<xref ref-type="bibr" rid="scirp.109483-ref7">7</xref>] and 50% in Madagascar [<xref ref-type="bibr" rid="scirp.109483-ref8">8</xref>].</p><p>In Mali, in one study digestive bleeding by esophageal varices rupture accounted for 2.5% of hospitalizations with a mortality rate of 48% [<xref ref-type="bibr" rid="scirp.109483-ref9">9</xref>]. Another study reported 14% frequency of digestive bleeding per esophageal varicose rupture in cirrhotics with a mortality of 27.3% [<xref ref-type="bibr" rid="scirp.109483-ref10">10</xref>]. These mortality rates were reported incidentally and the associated factors were not studied. Given the frequency of this evolutionary accident during cirrhosis, we undertook this study with the aim of reassessing its prognosis and the value of transfusion on it.</p></sec><sec id="s2"><title>2. Patients and Methods</title><p>This was a prospective study that took place in the Hepato-Gastroenterology department of the CHU-Gabriel TOURE from June 2016 to May 2017 and from November 2017 to August The study looked at patients admitted to the department for gastrointestinal bleeding by a rupture of esophageal varices retained on the following criteria: active bleeding from esophageal varices, clot on the esophageal varice, oozing mucosa in the presence of esophageal varices, esophageal varices without bleeding stigma associated with the presence of blood in the stomach without other cause of retained bleeding. The exclusionary criteria were. Digestive hemorrhage not related to rupture of esophageal varicose veins.</p><p>Patients who received a transfusion were compared to patients who didn’t receive the transfusion. All patients collected received a comprehensive clinical examination looking for a history (jaundice, hematemesis, melena, rectorragia and any other known pathology) and signs of HTP and hepatocellular insufficiency. Biological examinations were primarily aimed at assessing hemodynamic resonance (hemoglobin levels, hematocrite levels, creatininemia) and hepatocellular function (TP, total bilirubinemia and protides electrophoresis). At the end of this procedure, a blood transfusion was indicated with systolic blood pressure of 90 mm Hg or less and/or hemoglobin levels below 7 g/dL, plus or minus a pulse greater than 110 pulses per minute. Ligation of esophageal varicose veins was performed in some patients.</p><p>Upper gastrointestinal endoscopy looked for criteria attributing digestive hemorrhage to rupture of esophageal Varices. Abdominal ultrasound assessed signs of portal hypertension and liver morphology. All patients were informed and gave verbal consent. The data was collected on a fact sheet and analyzed on co-info version 6.04. The Khi2 test was used to compare our results which were significant for a probability p &lt; 0.05.</p></sec><sec id="s3"><title>3. Results</title><p>At the end of the study, 77 patients met the inclusion criteria out of 1396 patients hospitalized during the same period, representing a hospital frequency of 5.5%. The male sex was predominant with a sex ratio of 1.9. The average age was 46.6 &#177; 15.1 years with extremes of 21 and 86 years. In 49.4% of the cases the patients were between 31 and 50 years old. Housewives and farmers were the most represented with 31.2% and 22.1% respectively. History of jaundice (26.4%), unexplored hematemesis (23.1%) and melena (22%) were the most frequently reported (<xref ref-type="table" rid="table1">Table 1</xref>). On physical examination, pallor (63.2%), ascites (58.4% and low blood pressure (42.8%) (<xref ref-type="table" rid="table2">Table 2</xref>). Biologically, severe anemia was retroved in 50.6% of patients. In 12.9% of cases the rate of prothrombine was less than 40%. Hypoalbuminemia &lt; 28 g/L was observed in 42.1% of cases. Hyper creatininemia was observed in 27.5% of cases (<xref ref-type="table" rid="table3">Table 3</xref>). Transfusion was reported in 47 patients (61%) with total blood used in 83% of cases and an average of 3.2 &#177; 2.2 transfused pockets. Esophageal varicose vein ligation was made in 17 of our patients, or 22.1%. The trend was marked by a definitive cessation of hemorrhage in 68.8% of cases, a recurrence in 7.8% of cases and a mortality of 23.4%.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Patient history</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >History</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Jaundice</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >26.4</td></tr><tr><td align="center" valign="middle" >Unexplored hematesis</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >23.1</td></tr><tr><td align="center" valign="middle" >Melena</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >22</td></tr><tr><td align="center" valign="middle" >Bilharzia</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >9.9</td></tr><tr><td align="center" valign="middle" >Arterial Hypertension</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >7.7</td></tr><tr><td align="center" valign="middle" >Diabete</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2.2</td></tr><tr><td align="center" valign="middle" >Rectorragia</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2.2</td></tr><tr><td align="center" valign="middle" >Others*</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >6.5</td></tr></tbody></table></table-wrap><p>*Sickle cell disease: 1; hyperthyroidism: 1; asthma: 1; blindness: 1; poliomyelitis: 1: pulmonary tuberculosis: 1.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Physical signs at admission</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Physical signs at admission</th><th align="center" valign="middle" >Frequency N = 77</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Conjunctivale Paleness</td><td align="center" valign="middle" >48</td><td align="center" valign="middle" >63.2</td></tr><tr><td align="center" valign="middle" >Ascite</td><td align="center" valign="middle" >45</td><td align="center" valign="middle" >58.4</td></tr><tr><td align="center" valign="middle" >Arterial hypotension</td><td align="center" valign="middle" >33</td><td align="center" valign="middle" >42.8</td></tr><tr><td align="center" valign="middle" >Hepatomegaly</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >27.27</td></tr><tr><td align="center" valign="middle" >Splenomegaly</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >22.1</td></tr><tr><td align="center" valign="middle" >Collateral Veinous Circulation</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >17.1</td></tr><tr><td align="center" valign="middle" >alteration of consciousness</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >14.3</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Biological signs at admission</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"  >Biological Signs</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Hemoglobin Rate (g/dL)</td><td align="center" valign="middle" >&lt;7 7 - 9 10 - 12 &gt;12</td><td align="center" valign="middle" >39 15 17 6</td><td align="center" valign="middle" >50.6 19.5 22.1 7.8</td></tr><tr><td align="center" valign="middle" >Hematocrite rate (%)</td><td align="center" valign="middle" >&lt;21 21 - 35 &gt;35</td><td align="center" valign="middle" >37 33 7</td><td align="center" valign="middle" >48.1 42.8 9.1</td></tr><tr><td align="center" valign="middle" >Prothrombine rate (%)</td><td align="center" valign="middle" >&lt;40 40 - 50 &gt;50</td><td align="center" valign="middle" >8 14 40</td><td align="center" valign="middle" >12.9 22.6 64.5</td></tr><tr><td align="center" valign="middle" >Creatininemia (&#181;mol/l)</td><td align="center" valign="middle" >&gt;120 &lt;120</td><td align="center" valign="middle" >19 50</td><td align="center" valign="middle" >27.5 72.5</td></tr><tr><td align="center" valign="middle" >Bilirubinemia (mmol/l) (n = 26)</td><td align="center" valign="middle" >&lt;35 35 - 50 &gt;50</td><td align="center" valign="middle" >15 3 8</td><td align="center" valign="middle" >57.7 11.5 30.8</td></tr><tr><td align="center" valign="middle" >Albuminemia (g/L) (N = 19)</td><td align="center" valign="middle" >&gt;35 g/L 28 - 35 g/L &lt;28 g/L</td><td align="center" valign="middle" >5 6 8</td><td align="center" valign="middle" >26.3 31.6 42.1</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Patient evolution by transfusion status</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Transfusion status Evolution</th><th align="center" valign="middle" >With transfusion N = 47 (61%)</th><th align="center" valign="middle" >Without transfusion N = 30 (39%)</th><th align="center" valign="middle" >Probability</th></tr></thead><tr><td align="center" valign="middle" >Definitive cessation of bleeding Early recidivism Deceased</td><td align="center" valign="middle" >33 6 8</td><td align="center" valign="middle" >20 0 10</td><td align="center" valign="middle" >p = 0.7432 p = 0.0452 p = 0.0990</td></tr></tbody></table></table-wrap><p>Hepatic encephalopathy was the leading cause of death with 72.2% of cases followed by hemorrhagic shock in 27.8%. Early recurrence was significantly observed in transfusions (p = 0.0452) and mortality was not statistically different between the two groups (p = 0.0990) (<xref ref-type="table" rid="table4">Table 4</xref>).</p></sec><sec id="s4"><title>4. Discussion</title><p>The hospital frequency of digestive bleeding by esophageal varice rupture may be underestimated by this study, as some patients died prior to performing a digestive endoscopy. Not all of the desired paraclinical examinations for the prognosis assessment could be performed in all patients due to lack of financial resources. However, the sample size and clinical and biological information collected from as many patients as possible provided a relevant analysis of this urgent evolutionary accident of cirrhotic disease. Digestive bleeding by esophageal varice rupture accounted for 5.5% of all hospitalizations during the study period. BOUGLOUGA et al. [<xref ref-type="bibr" rid="scirp.109483-ref5">5</xref>] had found a comparable frequency of 4%, while KONATE et al. [<xref ref-type="bibr" rid="scirp.109483-ref9">9</xref>], DIARRA et al. [<xref ref-type="bibr" rid="scirp.109483-ref10">10</xref>] reported lower frequencies of 2.5% and 1.6% respectively. The difference between the results of these last two studies and ours could be explained by the duration of the studies and the size of the samples that were higher in our case.</p><p>The average age of our patients of 46.6 &#177; 15.1 years is significantly higher than in other studies conducted in our country [<xref ref-type="bibr" rid="scirp.109483-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.109483-ref10">10</xref>] and Togo [<xref ref-type="bibr" rid="scirp.109483-ref6">6</xref>]. However, an upper average age of 64 years was reported by Heidi in Bordeaux [<xref ref-type="bibr" rid="scirp.109483-ref11">11</xref>]. The average age of patients in our study is comparable to that usually observed in cirrhosis studies in our context.</p><p>The male sex represented 67.5% of the sample. The same findings were made by other series [<xref ref-type="bibr" rid="scirp.109483-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.109483-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.109483-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.109483-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.109483-ref10">10</xref>], may be a change in men’s more frequent exposure to risk factors for cirrhosis that is complicated by this hemorrhage. Frequent representation of housewives (31.2%) farmers (22.1%) is superimposed on that found in other studies of cirrhosis in Mali (9, 10). The low standard of living of these social strata may contribute to frequent transmission and delay in the management of the hepatitis B virus (HBV), which is the leading cause of cirrhosis in Mali [<xref ref-type="bibr" rid="scirp.109483-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.109483-ref12">12</xref>]. Jaundice was found in 26.4% of our patients, comparable to the Diarraet al. [<xref ref-type="bibr" rid="scirp.109483-ref10">10</xref>] study which found 26.3%, while Konat&#233; et al. [<xref ref-type="bibr" rid="scirp.109483-ref9">9</xref>] reported a much higher frequency of 54%.</p><p>The frequency of signs of severe bleeding (paleness, low blood pressure and Hb &lt; 7 g/dL) warranted the indication of a blood transfusion in 61% of patients and 83% of these patients were transfused by total blood because of the constant unavailability of the more recommended erythrocytic nerve. The use of this total blood would explain the recurrence of the hemorrhage that was observed exclusively there. It also did not improve mortality compared to the non-transfused group (p-0.0990).</p><p>High mortality of 23.4% was reported by other series [<xref ref-type="bibr" rid="scirp.109483-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.109483-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.109483-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.109483-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.109483-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.109483-ref13">13</xref>] that involved digestive bleeding by esophageal varices rupture. Liver encephalopathy was the leading cause of death for our patients with 72.2%. This finding was made by the Malian series [<xref ref-type="bibr" rid="scirp.109483-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.109483-ref10">10</xref>], respectively 29.2% and 15.2%, and 50% in TOGO [<xref ref-type="bibr" rid="scirp.109483-ref6">6</xref>].</p></sec><sec id="s5"><title>5. Conclusion</title><p>Digestive bleeding by rupture of esophageal varices is one of the most formidable complications of cirrhosis, frequently encountered in hospitals, with a sometimes high mortality rate. The prognosis can be improved by acquiring more efficient resuscitation means. Universal vaccination against HBV, the leading cause of cirrhosis in Mali, could reduce the frequency of this condition and mortality from esophageal varices rupture.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Doumbia, K., Sow, H., Dicko, M.Y., Sanogo, S.D., Tounkara, M.S., P&#233;liaba, K., Koumar&#233;, M., Soumar&#233;, G., Konat&#233;, A., Diarra, M.T. and Maiga, M.Y. (2021) Digestive Bleeding by Rupture of Esophageal Varicose Veins and Prognosis Value of Blood Transfusion in the Hepatogastroenterology Department of the Gabriel Toure Hospital. Open Journal of Gastroenterology, 11, 75-80. https://doi.org/10.4236/ojgas.2021.115008</p></sec></body><back><ref-list><title>References</title><ref id="scirp.109483-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Cales, P. and Pascal, J.P. (1988) Histoire naturelle des varices &amp;#339;sophagiennes au cours de la cirrhose (de la naissance à la rupture). Gastroentérologie Clinique et Biologique, 12, 245-254.</mixed-citation></ref><ref id="scirp.109483-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Thabut, D., Massard, J., Rudler, M. and Carbonell, N. (2007) Prise en charge des hémorragies digestives liées à l’hypertension portale. Réanimation, 16, 568-575.https://doi.org/10.1016/j.reaurg.2007.08.008</mixed-citation></ref><ref id="scirp.109483-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Billey, C. and Bureau, C. (2016) Hémorragie digestive par hypertension portale: 6ème conférence de Baveno, avril 2015 “Stratifier le risque et individualiser la prise en charge de l’hypertension portale”, Post’U, 37-43.</mixed-citation></ref><ref id="scirp.109483-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Bosch, J. (2000) Facteurs prédictifs de l’hémorragie digestive par rupture de varices &amp;#339;sophagiennes. Actaendoscopisca, 30, 531-535. https://doi.org/10.1007/BF03026170</mixed-citation></ref><ref id="scirp.109483-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Dominique Paterson (2004) Prise en charge des hémorragies digestives aigu&amp;#235;s.https://www.em-consulte.com/</mixed-citation></ref><ref id="scirp.109483-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Bouglouga, O., Bagny, A., Lawson, L. and Djibril, M. (2014) Mortalité hospitalière liée à une hémorragie digestive haute par rupture de varices &amp;#339;sophagiennes au CHU Campus de Lomé (Togo). Médecine et Santé Tropicales, 24, 388-391.https://doi.org/10.1684/mst.2014.0372</mixed-citation></ref><ref id="scirp.109483-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Ye, M. (2002) Les hémorragies digestives à l’h&amp;#244;pital national de BOBO-DIOULASSO These Med, BOBO, 38.</mixed-citation></ref><ref id="scirp.109483-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Razafimahefa, S.H., Rabenjanahary, T.H. and Rakotozafindraibe, R. (year) Hémorragies digestives hautes: Aspects cliniques, endoscopiques et évolutifs—A propos d’une série de 62 patients malgaches. RMM2011, 1, 6-10.</mixed-citation></ref><ref id="scirp.109483-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Konaté, A., Diarra, M.T., Soukho, A., Katilé, D., Soumaré, G., Kallé, A., et al. (2008) Hémorragies digestives par rupture de varices &amp;#339;sophagiennes. Mali Medical, 23, 32-35.</mixed-citation></ref><ref id="scirp.109483-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Diarra, M.T., Konate, A., Soukho, A., Epouse, K., Dicko, M., Kallé, A., Doumbia, K. Epouse, S. et al. (2010) Aspects évolutifs de la maladie cirrhotique dans un service d’hépato-gastro-entérologie au Mali. Mali Médical, 25, 42-46.</mixed-citation></ref><ref id="scirp.109483-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Heidi, Z. (2014) Prise en charge pré hospitalière des hémorragies digestives hautes au SAMU 33 de Bordeaux. Thèse de médecine, Bordeaux, 66.</mixed-citation></ref><ref id="scirp.109483-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Doumbia, K., Diarra, M., Konaté, A., Sow, H., Soukh, A., et al. (2012) L’ascite, une complication péjorative chez le cirrhotique en milieu tropical, au Mali. Médecine d’Afrique Noire, 59, 274-278.</mixed-citation></ref><ref id="scirp.109483-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Ennassiri, W. (2010) Hémorragies digestives hautes en milieu de réanimation à propos de 80 cas. Thèse de médecine, Marrakech, 8.</mixed-citation></ref></ref-list></back></article>